Cargando…
Global access to affordable direct oral anticoagulants
Poor control of cardiovascular disease accounts for a substantial proportion of the disease burden in developing countries, but often essential anticoagulant medicines for preventing strokes and embolisms are not widely available. In 2019, direct oral anticoagulants were added to the World Health Or...
Autores principales: | Neumann, Ignacio, Schünemann, Holger J, Bero, Lisa, Cooke, Graham, Magrini, Nicola, Moja, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381095/ https://www.ncbi.nlm.nih.gov/pubmed/34475602 http://dx.doi.org/10.2471/BLT.20.278473 |
Ejemplares similares
-
The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance
por: Zanichelli, Veronica, et al.
Publicado: (2023) -
Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022) -
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
por: Wouters, Olivier J, et al.
Publicado: (2021) -
Access to hepatitis C medicines
por: Edwards, Danny J, et al.
Publicado: (2015) -
Missing data on accessibility of children’s medicines
por: Joosse, Iris R, et al.
Publicado: (2022)